Hormones are chemicals made by glands, such as the ovaries and testicles. Hormones help some types of cancer cells grow, such as breast cancer, prostate cancer. In other cases, hormones can kill cancer cells, make cancer cells grow more slowly, or stop them from growing. Hormone therapy as a cancer treatment may involve taking medicines that block the activity of the hormone or stop the body from making the hormone. Hormone therapy may involve surgically removing a gland that is making the hormones.
If you have breast cancer, your healthcare provider may advise a hormone receptor test of the tumour. It can help determine treatment options and help learn more about the tumour. This test can help to predict whether the cancer cells are sensitive to hormones.
The hormone receptor test measures the amount of certain proteins (called hormone receptors) in cancer tissue. Hormones that naturally occur in the body (such as oestrogen and progesterone) can attach to these proteins and help them grow. If the test is positive, the hormone is probably helping the cancer cells to grow. In this case, hormone therapy may be given to block the way the hormone works and help keep the hormone away from the cancer cells (hormone receptors). If the test is negative, the hormone does not affect the growth of the cancer cells. Other helpful cancer treatments may be given. Always talk with your healthcare provider about the results of the hormone receptor test.
If the test suggests that the hormones are affecting your cancer, the cancer may be treated in one of these ways:
The type of hormone therapy a person gets depends on many factors, such as:
Your healthcare provider may give you hormone therapies before or after other cancer treatments. If hormone therapy is given before the primary treatment, it is called neoadjuvant treatment. These treatments help to kill cancer cells. They also help make the primary therapy, which is often surgery, work better. If hormone therapy is given after the primary treatment, it is called adjuvant treatment. Adjuvant therapy is given to improve the chance of a cure.
With some cancers, hormone therapy is given as soon as cancer is diagnosed, and before any other treatment. It may shrink a tumour. Or it may halt the growth of the disease.
Hormone therapy may be used to prevent the growth, spread, and recurrence of breast cancer. The female hormone oestrogen can increase the growth of breast cancer cells in some women. An example of this type of medicine is tamoxifen. It works by blocking the effects of oestrogen on the growth of cancer cells in breast tissue. But tamoxifen does not stop the production of oestrogen. Men who have breast cancer may also be treated with tamoxifen.
Tamoxifen is now being studied as a hormone therapy for treatment of other types of cancer. There are several other hormonal agents for breast cancer that target the oestrogen receptor like tamoxifen, such as toremifene and fulvestrant.
Hormone therapy may be used for women whose breast cancers test positive for oestrogen or progesterone receptors.
Aromatase inhibitors are newer medicines approved by the U.S. Food and Drug Administration (FDA). They are used to treat advanced breast cancer or prevent the recurrence of breast cancer in postmenopausal women. These medicines prevent oestrogen production in postmenopausal women. They may be the medicine of choice for women who are past menopause. They include anastrozole, letrozole, and exemestane.
The FDA approved the use of raloxifene for postmenopausal women who are at high risk for breast cancer. It is also given to women who have osteoporosis. Raloxifene is not for use in premenopausal women. It now joins tamoxifen as another medicine that can be used to help at-risk women lower their risk of invasive breast cancer.
Fulvestrant is also approved by the FDA. It binds with the oestrogen receptor and eliminates it, rather than just blocking it. It makes oestrogen less effective in promoting growth of the cancer.
With prostate cancer, there may be a variety of medicines used in hormone therapy. Male hormones, such as testosterone, stimulate prostate cancer to grow. Hormone therapy is given to help stop hormone production and to block the activity of the male hormones. Hormone therapy can cause a tumour to shrink and the prostate-specific antigen levels to decrease.
The following are some potential side effects that may occur with hormone therapy. However, the side effects will vary depending on the type of hormone therapy that is given. Every person’s hormone treatment experience is different and not every person will experience the same side effects. Discuss the potential side effects of your hormone therapy with your doctor.
As each person’s individual medical profile and diagnosis is different, so is his or her reaction to treatment. Side effects may be severe, mild, or absent. Be sure to discuss possible side effects of treatment with your cancer care team before the treatment begins.
For prostate cancer, either the surgical removal of the testes or hormone drug therapy can improve the cancer. Both surgery and drugs may cause the following side effects:
For breast cancer, some women may experience side effects from tamoxifen that are similar to the symptoms some women experience in menopause. Other women do not experience any side effects when taking tamoxifen. The following are some of the side effects that may occur when taking tamoxifen:
Tamoxifen should not be taken during pregnancy. Taking it slightly raises the risk for: